|  | Dominant HGS | Relative HGS | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Gender | Q1 | Q2 | Q3 | Q4 | Â | Q1 | Q2 | Q3 | Q4 | Â | |
Men | <37 | 37 to 44 | 44 to 51 | ≥51 | Continuous (Per SD) | <2.6 | 2.6 to 3.2 | 3.2 to 3.7 | ≥3.7 | Continuous (Per SD) | |
Women | <22 | 22 to 27 | 27 to 31 | ≥31 | <1.6 | 1.6 to 2.0 | 2.0 to 2.4 | ≥2.4 | |||
Model 0 | Â | 1 | 0.72 (0.67-0.77) | 0.65 (0.60-0.70) | 0.60 (0.55-0.64) | 0.93 (0.91-0.96) | 1 | 0.69 (0.65-0.74) | 0.48 (0.45-0.51) | 0.26 (0.24-0.29) | 0.73 (0.71-0.75) |
Model 1 | Â | 1 | 0.79 (0.74-0.85) | 0.75 (0.70-0.81) | 0.74 (0.69-0.81) | 0.85 (0.82-0.89) | 1 | 0.71 (0.67-0.76) | 0.50 (0.46-0.54) | 0.28 (0.25-0.31) | 0.56 (0.54-0.58) |
Model 2 | Â | 1 | 0.81 (0.75-0.87) | 0.75 (0.69-0.81) | 0.71 (0.66-0.77) | 0.83 (0.80-0.86) | 1 | 0.88 (0.82-0.94) | 0.72 (0.66-0.78) | 0.49 (0.44-0.54) | 0.73 (0.70-0.76) |
Model 3 | Â | 1 | 0.88 (0.81-0.94) | 0.82 (0.76-0.89) | 0.85 (0.78-0.93) | 0.92 (0.88-0.96) | 1 | 0.95 (0.89-1.02) | 0.82 (0.76-0.89) | 0.60 (0.54-0.67) | 0.81 (0.77-0.85) |